Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
Authors
Keywords
-
Journal
Cells
Volume 11, Issue 8, Pages 1370
Publisher
MDPI AG
Online
2022-04-19
DOI
10.3390/cells11081370
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Focal Adhesion Kinase Drives Resistance to Therapy in HPV-Negative Head and Neck Squamous Cell Carcinoma in a p53-Dependent Manner
- (2022) P. Pifer et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas
- (2021) Tenny Mudianto et al. CLINICAL CANCER RESEARCH
- RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
- (2021) Omprakash Shriwas et al. BRITISH JOURNAL OF CANCER
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma
- (2021) Tracy T. Tang et al. MOLECULAR CANCER THERAPEUTICS
- Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity
- (2021) Joel D. Pearson et al. CANCER CELL
- Nasopharyngeal carcinoma: an evolving paradigm
- (2021) Kenneth C. W. Wong et al. Nature Reviews Clinical Oncology
- Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling
- (2021) Baoyuan Zhang et al. Advanced Science
- ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers
- (2021) Albina Fejza et al. Cancers
- Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling
- (2021) Dana J. Ramms et al. PHARMACOLOGICAL REVIEWS
- EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1
- (2021) Toshinori Ando et al. Communications Biology
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma
- (2020) Hirofumi Omori et al. Science Advances
- Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells
- (2020) Garry L. Coles et al. CANCER CELL
- Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) David G. Pfister et al. Journal of the National Comprehensive Cancer Network
- Time‐varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973‐2015
- (2020) Andrew F. Brouwer et al. CANCER
- Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway
- (2020) Annie Wai Yeeng Chai et al. eLife
- Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
- (2020) Ievgenia Pastushenko et al. NATURE
- Head and neck squamous cell carcinoma
- (2020) Daniel E. Johnson et al. Nature Reviews Disease Primers
- A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
- (2019) Xiaodong Feng et al. CANCER CELL
- The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel
- (2019) Jacqueline E. Mann et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy
- (2019) Victoria Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Hippo Signaling Pathway in Development and Disease
- (2019) Yonggang Zheng et al. DEVELOPMENTAL CELL
- The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma
- (2019) Jin Li et al. Cell Death & Disease
- A Phase Ib Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity-Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
- (2019) Lara A. Dunn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- Analyzing expression and phosphorylation of the EGF receptor in HNSCC
- (2019) Malte Kriegs et al. Scientific Reports
- Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
- (2019) Zhiyong Wang et al. Nature Communications
- YAP/TAZ initiates gastric tumorigenesis via upregulation of MYC
- (2018) Wonyoung Choi et al. CANCER RESEARCH
- The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study
- (2018) Renata Abrahão et al. INTERNATIONAL JOURNAL OF CANCER
- Tension-dependent regulation of mammalian Hippo signaling through LIMD1
- (2018) Consuelo Ibar et al. JOURNAL OF CELL SCIENCE
- YAP/TAZ upstream signals and downstream responses
- (2018) Antonio Totaro et al. NATURE CELL BIOLOGY
- Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway
- (2018) Ramón García-Escudero et al. ORAL ONCOLOGY
- PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
- (2018) Otto Kauko et al. Science Translational Medicine
- Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade
- (2018) Winson S. Ho et al. Nature Communications
- Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
- (2018) Daniel Martin et al. Nature Communications
- The Hippo Signaling Network and its Biological Functions
- (2018) Jyoti R. Misra et al. Annual Review of Genetics
- Targeting G protein-coupled receptor signalling by blocking G proteins
- (2018) Adrian P. Campbell et al. NATURE REVIEWS DRUG DISCOVERY
- The Hippo Pathway: Biology and Pathophysiology
- (2018) Shenghong Ma et al. Annual Review of Biochemistry
- Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers
- (2018) Hui Cheng et al. Cell Reports
- Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
- (2018) Yumeng Wang et al. Cell Reports
- Mechanical properties of basement membrane in health and disease
- (2017) R. Tyler Miller MATRIX BIOLOGY
- Clinical significance of YAP1 activation in head and neck squamous cell carcinoma
- (2017) Young-Gyu Eun et al. Oncotarget
- Homeostatic Control of Hpo/MST Kinase Activity through Autophosphorylation-Dependent Recruitment of the STRIPAK PP2A Phosphatase Complex
- (2017) Yonggang Zheng et al. Cell Reports
- The Epithelial Circumferential Actin Belt Regulates YAP/TAZ through Nucleocytoplasmic Shuttling of Merlin
- (2017) Kana T. Furukawa et al. Cell Reports
- SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK
- (2017) Sung Jun Bae et al. eLife
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial
- (2016) Ravindra Uppaluri et al. CLINICAL CANCER RESEARCH
- Non-Photoinduced Biological Properties of Verteporfin
- (2016) Floriane Gibault et al. CURRENT MEDICINAL CHEMISTRY
- YAP/TAZ as therapeutic targets in cancer
- (2016) Francesca Zanconato et al. CURRENT OPINION IN PHARMACOLOGY
- Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma
- (2016) Ki Tae Kim et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
- (2016) Shanthi Marur et al. MAYO CLINIC PROCEEDINGS
- Characterization of Hippo Pathway Components by Gene Inactivation
- (2016) Steven W. Plouffe et al. MOLECULAR CELL
- Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
- (2016) PuiYee Chan et al. Nature Chemical Biology
- A comprehensive map of molecular drug targets
- (2016) Rita Santos et al. NATURE REVIEWS DRUG DISCOVERY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Roles of NDR Protein Kinases in Hippo Signalling
- (2016) Alexander Hergovich Genes
- Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy
- (2016) Wen Juan et al. Genes
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway
- (2015) Youjun Li et al. CELL RESEARCH
- NDR Functions as a Physiological YAP1 Kinase in the Intestinal Epithelium
- (2015) Lei Zhang et al. CURRENT BIOLOGY
- A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
- (2015) Toshiro Moroishi et al. GENES & DEVELOPMENT
- Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP
- (2015) Qian Chen et al. GENES & DEVELOPMENT
- The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma
- (2015) KYOHEI YOSHIKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Adhesion to fibronectin regulates Hippo signaling via the FAK–Src–PI3K pathway
- (2015) Nam-Gyun Kim et al. JOURNAL OF CELL BIOLOGY
- A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma
- (2015) S. E. Hiemer et al. MOLECULAR CANCER RESEARCH
- The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
- (2015) Zhongwu Li et al. Molecular Oncology
- Inactivation of a Gα s –PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis
- (2015) Ramiro Iglesias-Bartolome et al. NATURE CELL BIOLOGY
- Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
- (2015) Francesca Zanconato et al. NATURE CELL BIOLOGY
- Mechanical strain induces E-cadherin-dependent Yap1 and -catenin activation to drive cell cycle entry
- (2015) B. W. Benham-Pyle et al. SCIENCE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
- (2015) Zhipeng Meng et al. Nature Communications
- Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
- (2015) Wenqi Wang et al. Cell Reports
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
- (2014) Luca Azzolin et al. CELL
- The clinical development of MEK inhibitors
- (2014) Yujie Zhao et al. Nature Reviews Clinical Oncology
- Extracellular matrix assembly: a multiscale deconstruction
- (2014) Janna K. Mouw et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Biology of YAP/TAZ: Hippo Signaling and Beyond
- (2014) Stefano Piccolo et al. PHYSIOLOGICAL REVIEWS
- A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
- (2013) Mariaceleste Aragona et al. CELL
- Regulation of Hippo Signaling by EGFR-MAPK Signaling through Ajuba Family Proteins
- (2013) B.V.V.G. Reddy et al. DEVELOPMENTAL CELL
- cAMP/PKA signalling reinforces the LATS–YAP pathway to fully suppress YAP in response to actin cytoskeletal changes
- (2013) Minchul Kim et al. EMBO JOURNAL
- Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis
- (2013) Zicheng Wei et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
- (2013) Luc G T Morris et al. NATURE GENETICS
- Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1
- (2013) R. Fan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein Interaction Network of the Mammalian Hippo Pathway Reveals Mechanisms of Kinase-Phosphatase Interactions
- (2013) A. L. Couzens et al. Science Signaling
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Collagen as a double-edged sword in tumor progression
- (2013) Min Fang et al. TUMOR BIOLOGY
- Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
- (2012) Fa-Xing Yu et al. CELL
- Role of TAZ as Mediator of Wnt Signaling
- (2012) Luca Azzolin et al. CELL
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
- (2012) B. Zhao et al. GENES & DEVELOPMENT
- Function and cancer genomics of FAT family genes
- (2012) MASARU KATOH INTERNATIONAL JOURNAL OF ONCOLOGY
- SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse Functions
- (2012) Ghia Euskirchen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals
- (2012) S Moleirinho et al. ONCOGENE
- Crystal structure of a Tankyrase-Axin complex and its implications for Axin turnover and Tankyrase substrate recruitment
- (2012) S. Morrone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness
- (2011) N. P. Judd et al. CANCER RESEARCH
- Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation
- (2011) Karin Schlegelmilch et al. CELL
- Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
- (2011) B. Zhao et al. GENES & DEVELOPMENT
- Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP
- (2011) L Angus et al. ONCOGENE
- Yes-Associated Protein Expression in Head and Neck Squamous Cell Carcinoma Nodal Metastasis
- (2011) Lin Ge et al. PLoS One
- Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance
- (2011) D. Zhou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components
- (2011) N.-G. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
- (2010) John Araujo et al. CANCER TREATMENT REVIEWS
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
- (2010) Nailing Zhang et al. DEVELOPMENTAL CELL
- Kibra Functions as a Tumor Suppressor Protein that Regulates Hippo Signaling in Conjunction with Merlin and Expanded
- (2010) Jianzhong Yu et al. DEVELOPMENTAL CELL
- The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation
- (2010) I. Lian et al. GENES & DEVELOPMENT
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCPE3 Ligase
- (2010) Chen-Ying Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas
- (2010) Tine M. Søland et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets
- (2010) R Ehsanian et al. ONCOGENE
- Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period Analysis
- (2010) D. Pulte et al. ONCOLOGIST
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- The Emerging Role of the Hippo Pathway in Cell Contact Inhibition, Organ Size Control, and Cancer Development in Mammals
- (2008) Qi Zeng et al. CANCER CELL
- A crucial role of WW45 in developing epithelial tissues in the mouse
- (2008) Joo-Hyeon Lee et al. EMBO JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now